A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 12,675 shares of XERS stock, worth $43,095. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,675
Previous 12,421 2.04%
Holding current value
$43,095
Previous $35,000 20.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 10, 2025

BUY
$2.78 - $3.73 $706 - $947
254 Added 2.04%
12,675 $42,000
Q3 2024

Oct 23, 2024

BUY
$2.06 - $2.96 $25,587 - $36,766
12,421 New
12,421 $35,000

Others Institutions Holding XERS

About Xeris Biopharma Holdings, Inc.


  • Ticker XERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,956,992
  • Market Cap $462M
  • Description
  • Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...
More about XERS
Track This Portfolio

Track Wealth Enhancement Advisory Services, LLC Portfolio

Follow Wealth Enhancement Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Enhancement Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Enhancement Advisory Services, LLC with notifications on news.